Hims & Hers Jumps on Personalization, Weight-Loss Program Demand

  • Sees “early signs of traction” for weight-loss program
  • Telehealth provider’s forecast, results beat estimates
Lock
This article is for subscribers only.

Hims & Hers Health Inc. jumped as much as 21% in postmarket trading Monday after it reported 2024 forecasts above estimates, banking on demand for personalized treatments and its new weight loss program.

The San Francisco-based company is forecasting revenue of $1.17 billion to $1.2 billion in 2024, up from $872 million last year. It’s on track to hit its first year of positive net income in 2024, Chief Executive Officer Andrew Dudum said in an earnings call.